Jordi Roca‐Ferrer

3.0k total citations
81 papers, 2.3k citations indexed

About

Jordi Roca‐Ferrer is a scholar working on Physiology, Pharmacology and Surgery. According to data from OpenAlex, Jordi Roca‐Ferrer has authored 81 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Physiology, 23 papers in Pharmacology and 20 papers in Surgery. Recurrent topics in Jordi Roca‐Ferrer's work include Asthma and respiratory diseases (51 papers), Inflammatory mediators and NSAID effects (21 papers) and Sinusitis and nasal conditions (19 papers). Jordi Roca‐Ferrer is often cited by papers focused on Asthma and respiratory diseases (51 papers), Inflammatory mediators and NSAID effects (21 papers) and Sinusitis and nasal conditions (19 papers). Jordi Roca‐Ferrer collaborates with scholars based in Spain, United States and France. Jordi Roca‐Ferrer's co-authors include César Picado, Joaquim Mullol, Antoni Xaubet, Laura Pujols, Isam Alobid, Mireya Fuentes, Eduardo López, Asunción Martínez‐Antón, Alfons Torregó and Manel Juan and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Jordi Roca‐Ferrer

78 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Roca‐Ferrer Spain 28 1.2k 674 661 536 452 81 2.3k
Laura Pujols Spain 27 885 0.7× 588 0.9× 701 1.1× 417 0.8× 314 0.7× 56 1.9k
R. Robert Schellenberg Canada 29 1.4k 1.1× 544 0.8× 218 0.3× 992 1.9× 198 0.4× 91 2.5k
Heung-Man Lee South Korea 24 384 0.3× 179 0.3× 276 0.4× 178 0.3× 88 0.2× 77 1.6k
Michael A. Kaliner United States 23 638 0.5× 441 0.7× 148 0.2× 316 0.6× 112 0.2× 37 1.5k
Hideaki Shirasaki Japan 21 826 0.7× 370 0.5× 80 0.1× 357 0.7× 60 0.1× 73 1.4k
Heung‐Man Lee South Korea 16 713 0.6× 158 0.2× 172 0.3× 406 0.8× 37 0.1× 56 1.9k
Kai‐Li Liang Taiwan 25 273 0.2× 305 0.5× 703 1.1× 241 0.4× 40 0.1× 92 1.8k
Mitsuko Kondo Japan 25 912 0.8× 213 0.3× 61 0.1× 1.1k 2.0× 67 0.1× 116 1.9k
Gehua Zhang China 21 415 0.3× 219 0.3× 254 0.4× 171 0.3× 58 0.1× 85 1.1k
Etsuko Tagaya Japan 23 697 0.6× 153 0.2× 78 0.1× 723 1.3× 88 0.2× 107 1.5k

Countries citing papers authored by Jordi Roca‐Ferrer

Since Specialization
Citations

This map shows the geographic impact of Jordi Roca‐Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Roca‐Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Roca‐Ferrer more than expected).

Fields of papers citing papers by Jordi Roca‐Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Roca‐Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Roca‐Ferrer. The network helps show where Jordi Roca‐Ferrer may publish in the future.

Co-authorship network of co-authors of Jordi Roca‐Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Roca‐Ferrer. A scholar is included among the top collaborators of Jordi Roca‐Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Roca‐Ferrer. Jordi Roca‐Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartra, Joan, et al.. (2024). Mast Cell Activation Profile and TFH13 Detection Discriminate Between Food Anaphylaxis and Sensitization. Journal of Investigational Allergology and Clinical Immunology. 35(3). 203–215. 2 indexed citations
2.
3.
Roca‐Ferrer, Jordi, Isam Alobid, Mireya Fuentes, et al.. (2023). Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues. Journal of Clinical Medicine. 12(23). 7357–7357. 1 indexed citations
4.
Picado, César, Joaquim Mullol, & Jordi Roca‐Ferrer. (2022). Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis. Journal of Allergy and Clinical Immunology. 151(2). 310–313. 8 indexed citations
5.
Roca‐Ferrer, Jordi, et al.. (2022). Effect of MP-AzeFlu in IL-1 beta-induced IL-6 and proinflammatory cytokines. Immunologic Research. 71(3). 488–496. 1 indexed citations
6.
Pujols, Laura, et al.. (2017). Altered expression and signalling of EP2 receptor in nasal polyps of AERD patients: role in inflammation and remodelling. Rhinology Journal. 54(3). 254–265. 6 indexed citations
7.
Alobid, Isam, Pedro Benítez, J.M. Guilemany, et al.. (2011). Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. Rhinology Journal. 49(5). 519–524. 44 indexed citations
8.
Mullol, Joaquim, et al.. (2011). Impact of cell culture methods on the outcomes of the in vitro inflammatory response in nasal polyps. Rhinology Journal. 49(5). 562–569. 3 indexed citations
9.
10.
Pujols, Laura, P. Benítez, Isam Alobid, et al.. (2008). Glucocorticoid therapy increases COX-2 gene expression in nasal polypsin vivo. European Respiratory Journal. 33(3). 502–508. 11 indexed citations
11.
Martínez‐Antón, Asunción, Jordi Roca‐Ferrer, & Joaquim Mullol. (2006). Mucin gene expression in rhinitis syndromes. Current Allergy and Asthma Reports. 6(3). 189–197. 10 indexed citations
12.
Torregó, Alfons, Laura Pujols, Jordi Roca‐Ferrer, et al.. (2004). Glucocorticoid Receptor Isoforms α and β in in Vitro Cytokine-induced Glucocorticoid Insensitivity. American Journal of Respiratory and Critical Care Medicine. 170(4). 420–425. 57 indexed citations
13.
Pujols, Laura, Joaquim Mullol, Jordi Roca‐Ferrer, et al.. (2002). Expression of glucocorticoid receptor α- and β-isoforms in human cells and tissues. American Journal of Physiology-Cell Physiology. 283(4). C1324–C1331. 179 indexed citations
14.
Mullol, Joaquim, Jordi Roca‐Ferrer, Laura Pujols, et al.. (2002). Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. Journal of Allergy and Clinical Immunology. 109(5). 824–830. 57 indexed citations
15.
Xaubet, Antoni, Joaquim Mullol, Jordi Roca‐Ferrer, et al.. (2001). Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells. Respiratory Medicine. 95(5). 408–414. 26 indexed citations
16.
Roca‐Ferrer, Jordi, Joaquim Mullol, Maria Perez, et al.. (2000). Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: Comparison between human upper and lower airways. Journal of Allergy and Clinical Immunology. 106(6). 1053–1062. 16 indexed citations
17.
Picado, César, Manel Juan, Jordi Roca‐Ferrer, et al.. (1999). Cyclooxygenase-2 mRNA Is Downexpressed in Nasal Polyps from Aspirin-sensitive Asthmatics. American Journal of Respiratory and Critical Care Medicine. 160(1). 291–296. 188 indexed citations
18.
Roca‐Ferrer, Jordi, Joaquim Mullol, Eduardo López, et al.. (1997). Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion. European Respiratory Journal. 10(7). 1489–1495. 49 indexed citations
19.
Mullol, Joaquim, Antoni Xaubet, Eduardo López, et al.. (1997). [Eosinophil activation by epithelial cells of the respiratory mucosa. Comparative study of normal mucosa and inflammatory mucosa].. PubMed. 109(1). 6–11. 3 indexed citations
20.
Mullol, Joaquim, Eduardo López, Jordi Roca‐Ferrer, et al.. (1997). Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Clinical & Experimental Allergy. 27(12). 1432–1441. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Pujols Breakdown of academic impact, for papers by R. Robert Schellenberg Breakdown of academic impact, for papers by Heung-Man Lee Breakdown of academic impact, for papers by Michael A. Kaliner Breakdown of academic impact, for papers by Hideaki Shirasaki Breakdown of academic impact, for papers by Heung‐Man Lee Breakdown of academic impact, for papers by Kai‐Li Liang Breakdown of academic impact, for papers by Mitsuko Kondo Breakdown of academic impact, for papers by Gehua Zhang Breakdown of academic impact, for papers by Etsuko Tagaya
Rankless by CCL
2026